Pfizer Inc. (PFE)
Pfizer CEO's Job Is at Risk. A Shot of Discipline Could Help.
As activist Starboard teams up with former Pfizer executives, the pharma giant's lack of focus is in the spotlight.
Watch These Pfizer Price Levels as Stock Gains After Report of Starboard Taking Stake
Pfizer (PFE) shares have gained ground since theThe Wall Street Journal reported over the weekend that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes at the company.
Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential
Pfizer, yielding 5.6%, is an Ultra SWAN bargain with upside potential in the next year. Despite $70 billion in debt, Pfizer's A- credit rating and stable cash flow ensure long-term stability and very strong dividend safety. Pfizer's growth outlook includes a 5% long-term growth rate, with a 10% to 11% long-term return potential.
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court.
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock has likely bottomed and shows strong technical and fundamental indicators, including a "Golden Cross" and robust cost reduction plans. The company's promising pipeline, including weight-loss treatments and AI-driven drug discovery, offers significant long-term upside potential. The Seagen acquisition enhances Pfizer's cancer treatment portfolio, positioning it well in a high-demand sector.
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Starboard Value has taken a $1 billion stake in drugmaker Pfizer. The hedge fund, headed by Jeff Smith, has become one of the most feared activist investors.
Pfizer needs to 'fix what they have', no M&A capacity, says BMO's Evan Seigerman on activist stake
Evan David Seigerman, BMO Biotech Analyst, joins 'Closing Bell Overtime' to talk Pfizer shares climbing on activist firm Starboard taking a stake in the company.
Chart of the Day: Pfizer
Starboard takes a $1 billion stake in $PFE. It's our Chart Of The Day.
Starboard Value takes up $1 billion stake in Pfizer: WSJ
Pharmaceutical giant Pfizer (PFE) is seeing stock gains in Monday's pre-market trading after activist investor Starboard Value took up a $1 billion stake, according to a Wall Street Journal report. Yahoo Finance senior health reporter Anjalee Khemlani covers Starboard's reported investment in Pfizer as the pharma company seeks to reposition itself coming out of the COVID-19 pandemic.
Pfizer (PFE) Surges on Starboard's $1 Billion Investment Plan
Pfizer (PFE, Financial) stock saw a notable increase of 2.94% attributed to a reported $1 billion investment by activist investor Starboard Value. This strategic move is intended to breathe new life into Pfizer, as the stock has experienced a substantial decrease from its highs during the pandemic era.
Why Pfizer Stock Popped on Monday
Can Starboard Value and former CEO Ian Read save Pfizer stock?
